Lanoxin



Indications and Reactions:

Role Indications Reactions
Primary
Drug Use For Unknown Indication 29.9%
Atrial Fibrillation 26.4%
Product Used For Unknown Indication 13.9%
Cardiac Failure 7.3%
Hypertension 5.6%
Arrhythmia 3.4%
Congestive Cardiomyopathy 1.6%
Cardiac Disorder 1.3%
Type 2 Diabetes Mellitus 1.3%
Hypothyroidism 1.1%
Myocardial Ischaemia 1.1%
Angina Pectoris 1.0%
Essential Hypertension 1.0%
Prophylaxis 1.0%
Anticoagulant Therapy 0.8%
Cardiac Failure Congestive 0.8%
Supraventricular Tachycardia 0.8%
Chronic Obstructive Pulmonary Disease 0.6%
Diabetes Mellitus 0.6%
Heart Rate Irregular 0.6%
Vomiting 15.7%
Therapeutic Agent Toxicity 15.2%
Medication Error 7.6%
Death 6.6%
Nausea 5.1%
Syncope 5.1%
Overdose 4.5%
Product Quality Issue 4.0%
Visual Impairment 4.0%
Bradycardia 3.5%
Drug Ineffective 3.5%
Somnolence 3.5%
Cardioactive Drug Level Increased 3.0%
Toxicity To Various Agents 3.0%
Visual Disturbance 3.0%
Weight Decreased 3.0%
Heart Rate Increased 2.5%
Loss Of Consciousness 2.5%
Nodal Arrhythmia 2.5%
Completed Suicide 2.0%
Secondary
Drug Use For Unknown Indication 18.7%
Depression 13.9%
Diabetes Mellitus 12.0%
Product Used For Unknown Indication 9.9%
Atrial Fibrillation 8.8%
Hypertension 6.5%
Tachyarrhythmia 5.9%
Cardiac Failure 4.3%
Dyslipidaemia 2.4%
Cardiac Failure Chronic 2.1%
High Density Lipoprotein Decreased 2.1%
Cardiac Failure Congestive 1.8%
Rheumatoid Arthritis 1.8%
Cardiac Disorder 1.7%
Ill-defined Disorder 1.6%
Hypothyroidism 1.4%
Arrhythmia 1.3%
Cardiomyopathy 1.3%
Self Injurious Behaviour 1.2%
Type 2 Diabetes Mellitus 1.2%
Vomiting 12.8%
Death 11.2%
Myocardial Infarction 11.2%
Syncope 8.0%
Pneumonia 5.6%
Therapeutic Agent Toxicity 5.6%
Weight Decreased 4.8%
Bradycardia 4.0%
Overdose 4.0%
Dyspnoea 3.2%
Hyponatraemia 3.2%
Hypotension 3.2%
Renal Disorder 3.2%
Renal Failure Acute 3.2%
Respiratory Arrest 3.2%
Sinus Bradycardia 3.2%
Toxicity To Various Agents 3.2%
Cardiac Failure Congestive 2.4%
Dizziness 2.4%
Drug Exposure During Pregnancy 2.4%
Concomitant
Product Used For Unknown Indication 30.1%
Drug Use For Unknown Indication 20.2%
Atrial Fibrillation 10.0%
Hypertension 7.4%
Cardiac Disorder 3.8%
Diabetes Mellitus 3.3%
Pain 2.9%
Cardiac Failure Congestive 2.1%
Rheumatoid Arthritis 2.1%
Pulmonary Arterial Hypertension 1.9%
Depression 1.8%
Osteoporosis 1.8%
Type 2 Diabetes Mellitus 1.7%
Blood Cholesterol Increased 1.7%
Chronic Obstructive Pulmonary Disease 1.7%
Multiple Myeloma 1.7%
Cardiac Failure 1.6%
Hormone Replacement Therapy 1.5%
Prophylaxis 1.4%
Pulmonary Hypertension 1.3%
Vomiting 11.9%
Weight Decreased 9.7%
Death 9.1%
Myocardial Infarction 8.1%
Weight Increased 6.3%
Transient Ischaemic Attack 5.1%
Nausea 4.7%
Pain 4.6%
Oedema Peripheral 4.4%
Dyspnoea 4.2%
International Normalised Ratio Increased 3.9%
Urinary Tract Infection 3.6%
Vision Blurred 3.6%
Sepsis 3.4%
Pneumonia 3.2%
Renal Failure Acute 3.1%
Renal Failure 2.9%
Syncope 2.8%
Unevaluable Event 2.8%
Drug Ineffective 2.6%
Interacting
Diabetes Mellitus 23.4%
Depression 22.4%
Tachyarrhythmia 11.2%
Atrial Fibrillation 6.5%
Dyslipidaemia 5.6%
Essential Hypertension 5.6%
High Density Lipoprotein Decreased 5.6%
Blood Cholesterol Increased 3.7%
Product Used For Unknown Indication 3.7%
Drug Use For Unknown Indication 2.8%
Angina Pectoris 1.9%
Hypercholesterolaemia 1.9%
Hypertensive Heart Disease 1.9%
Parkinson's Disease 1.9%
Hypokalaemia 0.9%
Palpitations 0.9%
Myocardial Infarction 50.0%
Drug Interaction 16.7%
Volume Blood Decreased 16.7%
Drug Ineffective 8.3%
Toxicity To Various Agents 8.3%